US Broker Ratings

Stryker Corporation (SYK) Stock Analysis: Exploring a 16% Upside Potential with Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry, is capturing investor attention with its robust market performance and promising growth outlook. Headquartered in Portage, Michigan, Stryker..

STERIS plc (Ireland) (STE)

⚠️ No article content returned.

..

Smith & Nephew (SNN) Stock Analysis: Exploring a 9.12% Potential Upside in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (SNN) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. Based in the United Kingdom, the company commands a..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside

Baxter International Inc. (NYSE: BAX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $10.83 billion, this..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating Growth with a 5.18% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC) has emerged as a prominent player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $39.85 billion,..

Novartis AG (NVS) Stock Analysis: Navigating Growth and Dividends in the Healthcare Sector

Novartis AG (NYSE: NVS), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and strategic innovations. As of its most recent trading session,..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking a 11.14% Potential Upside Amidst Robust Financials

For investors looking to tap into the pharmaceutical sector, AbbVie Inc. (NYSE: ABBV) offers an intriguing proposition. With a market capitalization of $388.97 billion, AbbVie stands as a formidable player..

Humana Inc. (HUM) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, stands as a compelling investment opportunity within the broader healthcare sector. With a market capitalization of $33.3 billion,..

Takeda Pharmaceutical Company L (TAK): Investor Outlook with 8.38% Potential Upside and Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable name in the global healthcare sector, stands as a compelling investment prospect for 2023. With a market capitalization of $54.28 billion, this..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Strong Buy with 15.19% Return on Equity and 3.53% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands tall in the biotechnology sector with a market capitalization of $84.42 billion, showcasing its robust presence in the healthcare industry. Based in Tarrytown, New..

GSK plc (GSK) Investor Outlook: Analyzing Growth Prospects in Healthcare with a 3.38% Dividend Yield

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, is a compelling company for investors eyeing the drug manufacturing industry. With a sprawling market cap of $101.84 billion,..

Johnson & Johnson (JNJ) Stock Analysis: Robust Dividend Yield and Promising Growth Potential

Johnson & Johnson (NYSE: JNJ) remains a formidable presence in the healthcare sector, with a market capitalization of $492.44 billion. Its diverse portfolio spans across two main segments: Innovative Medicine..

McKesson Corporation (MCK) Stock Analysis: Revenue Growth and Analyst Optimism Signal Potential Upside

Investors eyeing McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, have reason for optimism as the company continues to demonstrate robust revenue growth and receives strong support from..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A $210 Billion Healthcare Titan with 3.76% Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the medical instruments and supplies industry, continues to captivate investor attention thanks to its innovative approach in healthcare technology. With a market..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential Amid a Robust Revenue Surge

For investors with a keen interest in the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) presents an intriguing opportunity. With a market capitalization of $110.46 billion, HCA is a major..

UnitedHealth Group (UNH) Stock Analysis: A Compelling 14.5% Upside Potential for Investors

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to capture the attention of investors with its robust growth metrics and promising analyst ratings. With a market..

Merck & Company, Inc. (MRK) Stock Analysis: Investor Outlook with a Promising 2.54% Potential Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to draw investor interest due to its robust product pipeline and strategic partnerships. With a market capitalization..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Unpacking a 97.60% Potential Upside in the Biotech Arena

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is catching the attention of investors with its promising pipeline of monoclonal antibody therapeutics targeting inflammatory and immunology (I&I) diseases. Headquartered in Menlo Park, California,..

Rapport Therapeutics, Inc. (RAPP): Investor Outlook with a Promising 84.56% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its impressive 84.56% potential upside, as evidenced by the latest analyst ratings. As a clinical-stage biopharmaceutical company, Rapport Therapeutics is..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 92% Potential Upside in the Medical Technology Sector

AngioDynamics, Inc. (NASDAQ: ANGO), a notable player in the healthcare sector, has caught the attention of investors, not least because of its potential upside of over 92%, as per analyst..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds